Breaking News
0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details
Close

ACADIA Pharmaceuticals Inc (ACAD)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow ACADIA's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
20.84 -0.18    -0.86%
15:59:59 - Closed. Currency in USD ( Disclaimer )
After Hours
20.79
-0.05
-0.24%
17:46:01 - Real-time Data
Type:  Equity
Market:  United States
ISIN:  US0042251084 
CUSIP:  004225108
  • Volume: 2,038,903
  • Bid/Ask: 20.58 / 21.00
  • Day's Range: 20.36 - 21.60
ACADIA 20.84 -0.18 -0.86%
IndustryBiotechnology & Drugs
SectorHealthcare
Employees

601

Equity Type

ORD

ACADIA Pharmaceuticals Inc. (ACADIA) is a biopharmaceutical company. The Company is focused on the development and commercialization of medicines to address the medical needs in central nervous system disorders. The Company's lead product, NUPLAZID (pimavanserin), is used for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. ACADIA’s developments are focused on pimavanserin for additional neuropsychiatric conditions, trofinetide for Rett syndrome, ACP-044 for pain management and an early-stage muscarinic receptor program.

Contact Information

Phone +1-858-5582871
Fax 858-5582872

Top Executives

Name Age Since Title
Laura A. Brege 62 2008 Independent Director
Stephen R. Biggar 49 2016 Independent Chairman of the Board
Stephen R. Davis 59 2019 Director and Chief Executive Officer
Daniel B. Soland 62 2015 Independent Director
Srdjan R. Stankovic 63 2018 President
Edmund P. Harrigan 67 2015 Independent Director
Julian C. Baker 53 2016 Independent Director
James Michael Daly 58 2016 Independent Director
Austin D. Kim 56 2018 Executive Vice President, General Counsel, and Secretary
Elena H. Ridloff 40 2019 Executive Vice President, Chief Financial Officer
Ponni Subbiah - 2019 Senior Vice President, Global Head of Medical Affairs and Chief Medical Officer
Stephanie Fagan - 2019 Senior Vice President - Corporate Affairs, Chief Communications Officer
Mark Schneyer - 2020 Senior Vice President, Business Development and Chief Business Officer
James Kihara 40 2020 Principal Accounting Officer
Gudarz Davar - 2020 Executive Vice President - Head of Research and Development
Elizabeth A. Garofalo 63 2020 Director
Charmaine Lykins - - Senior Vice President - Global Product Planning, Chief Marketing Officer
Amanda Morgan - - Senior Vice President, Chief Revenue and Customer Officer
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

ACAD Comments

Write your thoughts about ACADIA Pharmaceuticals Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
St onks
St onks May 10, 2021 3:27PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
4197 close imo
joninge kvamme
joninge kvamme Mar 16, 2021 1:29PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
A italian journalist predict a new clinical trail for the sustrate. This will take time i suppose.
joninge kvamme
joninge kvamme Mar 15, 2021 4:01PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Somebody knows something.
joninge kvamme
joninge kvamme Mar 15, 2021 3:58PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
https://www.trefis.com/stock/acad/articles/510930/acadia-pharmaceuticals-stock-now-looks-oversold-at-27-levels/2021-03-15
joninge kvamme
joninge kvamme Mar 15, 2021 10:20AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Lowest downgrade is 27usd do...it can,t be that wrong.
joninge kvamme
joninge kvamme Mar 12, 2021 1:42PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Paperhands are out.
Marko Vizintin
Marko Vizintin Mar 12, 2021 12:36PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
30 next week
Ab High
Ab High Mar 12, 2021 11:06AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
joninge kvamme
joninge kvamme Mar 11, 2021 10:41AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Ok, some aftermarket
joninge kvamme
joninge kvamme Mar 10, 2021 12:17PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I am guessing this will fly in the aftermarket.
Simone Bertola
Simone Bertola Mar 10, 2021 8:17AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Why this stock is so down?
Lotiful Islam babu
Lotiful Islam babu Mar 10, 2021 1:36AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Today its go more dwon
Jobir Avezov
Jobir Avezov Mar 10, 2021 1:36AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Who knows it's green now but
Wojciech Stefaniak
Wojciech Stefaniak Mar 09, 2021 9:08AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
So I don't follow highly paid analysts' recommendations, they have their own business in it.
Jobir Avezov
Jobir Avezov Mar 09, 2021 9:08AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Is it good to buy at 25$?
Wojciech Stefaniak
Wojciech Stefaniak Mar 09, 2021 9:08AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Jobir Avezov   Yes, but don't be hurry, the time will come.
Jobir Avezov
Jobir Avezov Mar 09, 2021 9:08AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Thank you
Katherine MacFarquhar
Katherine MacFarquhar Feb 02, 2021 3:58PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Seems to have stalled. Is something happening
Theresa Harris
Theresa Harris Oct 21, 2020 9:26PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
here it'll be good
gene ray
gene ray Oct 13, 2020 7:41AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Buy, 2021 will be great
Pete Pearson
Pyxis2025 Aug 15, 2020 12:09AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
ACAD is a buy, we should see 5% higher next week.
Worker Worker
Worker Worker Jul 23, 2020 7:05AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
falling
Truong Loc Nguyen
Truong Loc Nguyen Jul 21, 2020 1:07PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Let's see where it's go from here
Kirill Danilov
Kirill Danilov Apr 09, 2020 3:39PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
What do you think the maximum will be by the end of April?
Michelle Saint
Michelle Saint Dec 05, 2019 12:47PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Great to buy now, holding
Aditya Chopra
Aditya Chopra Apr 09, 2018 4:00PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Why doesn’t the management come out and clarify?
Jet Fly
Jet Fly Jan 23, 2018 10:02AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
If ACAD breaks $33.45 resistance, it reaches $48 by end of March.
Michael William
Michael William Jan 23, 2018 10:02AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
this aged poorly
Michael William
Michael William Jan 23, 2018 10:02AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
this aged poorly
Pedro Martinez Sanz
Pedro Martinez Sanz Dec 23, 2016 1:12PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
29$, is buy or sell ?
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email